Crossref
Neurosteroids, GABAA receptors and neurosteroid based drugs: are we witnessing the dawn of the new psychiatric drugs?
Endocrine Oncology and Metabolism · 2016
DOI: 10.21040/eom/2016.2.7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine Oncology and Metabolism, 2016. Verfasst von Ante Tvrdeić und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tvrdeić, A., & Poljak, L. (2016). Neurosteroids, GABAA receptors and neurosteroid based drugs: are we witnessing the dawn of the new psychiatric drugs?. Endocrine Oncology and Metabolism. https://doi.org/10.21040/eom/2016.2.7
Vancouver
Tvrdeić A, Poljak L. Neurosteroids, GABAA receptors and neurosteroid based drugs: are we witnessing the dawn of the new psychiatric drugs?. Endocrine Oncology and Metabolism. 2016. doi:10.21040/eom/2016.2.7
BibTeX
@article{Tvrdei2016,
author = {Tvrdeić, Ante and Poljak, Ljiljana},
title = {Neurosteroids, GABAA receptors and neurosteroid based drugs: are we witnessing the dawn of the new psychiatric drugs?},
journal = {Endocrine Oncology and Metabolism},
year = {2016},
doi = {10.21040/eom/2016.2.7}
}
EUVIMED